5-Hydroxytryptamine augments migration of human aortic smooth muscle cells through activation of RhoA and ERK

Biochemical and Biophysical Research Communications

Volumn 337, Issue 3, 2005, Pages 916-921

  Matsusaka, Satoshi ^a   Wakabayashi, Ichiro ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

5 Hydroxytryptamine; Atherosclerosis; Cytoskeleton; MAP kinase; Serotonin; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 (3 DIMETHYLAMINOPROPYL) 4 HYDROXY N [4 (4 PYRIDINYL)PHENYL]BENZAMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; KETANSERIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; RHO KINASE INHIBITOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 2 ANTAGONIST;

ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL MIGRATION; CONCENTRATION (PARAMETERS); ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AORTA; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; RHOA GTP-BINDING PROTEIN; SEROTONIN;

UROPODA;

EID: 26844485076     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.129     Document Type: Article

References (24)

1. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
2. K. Miyata, Y. Oike, T. Hoshii, H. Maekawa, H. Ogawa, T. Suda, K. Araki, and K. Yamamura Increase of smooth muscle cell migration and intimal hyperplasia in mice lacking the α/β hydrolase domain containing 2 gene Biochem. Biophys. Res. Commun. 329 2005 296 304
3. K. Tamama, H. Tomura, K. Sato, E. Malchinkhuu, A. Damirin, T. Kimura, A. Kuwabara, M. Murakami, and F. Okajima High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component Atherosclerosis 178 2005 19 23
4. 2, and specific receptor antagonists on vascular smooth muscle cell proliferation Circulation 96 1997 2280 2286
5. S.K. Sharma, D.F. Del Rizzo, P. Zahradka, S.K. Bhangu, J.P. Werner, H. Kumamoto, N. Takeda, and N.S. Dhalla Sarpogrelate inhibits serotonin-induced proliferation of porcine coronary artery smooth muscle cells: implications for long-term graft patency Ann. Thorac. Surg. 71 2001 1856 1864
6. 2A antagonist, retards the progression of atherosclerosis through a novel mechanism Atherosclerosis 168 2003 23 31
7. D. Bottaro, D. Shepro, S. Peterson, and H.B. Hechtman Serotonin, histamine, and norepinephrine mediation of endothelial and vascular smooth muscle cell movement Am. J. Physiol. 248 1985 C252 C257
8. 2 receptors Atherosclerosis 132 1997 139 143
9. X.D. Ren, W.B. Kiosses, and M.A. Schwartz Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton EMBO J. 18 1999 578 585
10. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P. Humphrey International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) Pharmacol. Rev. 46 1994 157 203
11. Y. Liu, Y.J. Suzuki, R.M. Day, and B.L. Fanburg Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin Circ. Res. 95 2004 579 586
12. T. Kandabashi, H. Shimokawa, Y. Mukai, T. Matoba, I. Kunihiro, K. Morikawa, M. Ito, S. Takahashi, K. Kaibuchi, and A. Takeshita Involvement of rho-kinase in agonists-induced contractions of arteriosclerotic human arteries Arterioscler. Thromb. Vasc. Biol. 22 2002 243 248
13. F. Nishiguchi, R. Fukui, M. Hoshiga, N. Negoro, M. Ii, T. Nakakohji, E. Kohbayashi, T. Ishihara, and T. Hanafusa Different migratory and proliferative properties of smooth muscle cells of coronary and femoral artery Atherosclerosis 171 2003 39 47
14. I. Kiian, N. Tkachuk, H. Haller, and I. Dumler Urokinase-induced migration of human vascular smooth muscle cells requires coupling of the small GTPases RhoA and Rac1 to the Tyk2/PI3-K signaling pathway Thromb. Haemost. 89 2003 904 914
15. T.M. Seasholtz, M. Majumdar, D.D. Kaplan, and J.H. Brown Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration Circ. Res. 84 1999 1186 1193
16. H. Kishi, J. Bao, and K. Kohama Inhibitory effects of ML-9, wortmannin, and Y-27632 on the chemotaxis of vascular smooth muscle cells in response to platelet-derived growth factor-BB J. Biochem. (Tokyo) 128 2000 719 722
17. R.L. Klemke, S. Cai, A.L. Giannini, P.J. Gallagher, P. de Lanerolle, and D.A. Cheresh Regulation of cell motility by mitogen-activated protein kinase J. Cell Biol. 137 1997 481 492
18. J.K. Slack, A.D. Catling, S.T. Eblen, M.J. Weber, and J.T. Parsons c-Raf-mediated inhibition of epidermal growth factor-stimulated cell migration J. Biol. Chem. 274 1999 27177 27184
19. K. Roovers, and R.K. Assoian Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases Mol. Cell. Biol. 23 2003 4283 4294
20. G. Pawlak, and D.M. Helfman Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts Mol. Biol. Cell 13 2002 336 347
21. G. Pawlak, and D.M. Helfman MEK mediates v-Src-induced disruption of the actin cytoskeleton via inactivation of the Rho-ROCK-LIM kinase pathway J. Biol. Chem. 277 2002 26927 26933
22. K. Numaguchi, S. Eguchi, T. Yamakawa, E.D. Motley, and T. Inagami Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments Circ. Res. 85 1999 5 11
23. J. Alblas, L. Ulfman, P. Hordijk, and L. Koenderman Activation of RhoA and ROCK are essential for detachment of migrating leukocytes Mol. Biol. Cell 12 2001 2137 2145
24. S. Matsusaka, Y. Tohyama, J. He, Y. Shi, R. Hazama, T. Kadono, R. Kurihara, K. Tohyama, and H. Yamamura Protein-tyrosine kinase, Syk, is required for CXCL12-induced polarization of B cells Biochem. Biophys. Res. Commun. 328 2005 1163 1169